Credit Suisse Group set a GBX 5,800 ($75.79) target price on Reckitt Benckiser Group (LON:RB) in a research note issued to investors on Monday morning, Borsen Zeitung reports. The firm currently has a sell rating on the stock.

RB has been the subject of a number of other research reports. Goldman Sachs Group set a GBX 6,870 ($89.77) target price on shares of Reckitt Benckiser Group and gave the stock a neutral rating in a research note on Tuesday, June 25th. UBS Group downgraded shares of Telstra from a buy rating to a neutral rating in a research note on Monday, July 1st. Shore Capital reiterated a house stock rating on shares of in a research note on Wednesday, June 12th. Barclays reiterated an overweight rating and set a GBX 3,150 ($41.16) target price on shares of in a research note on Wednesday, June 5th. Finally, Morgan Stanley reiterated an overweight rating on shares of in a research note on Thursday, June 20th. Three analysts have rated the stock with a sell rating, four have assigned a hold rating and twelve have given a buy rating to the stock. Reckitt Benckiser Group currently has an average rating of Hold and an average target price of GBX 7,211.11 ($94.23).

Shares of RB stock traded up GBX 162 ($2.12) on Monday, reaching GBX 6,590 ($86.11). 1,969,940 shares of the stock were exchanged, compared to its average volume of 1,720,000. The company has a quick ratio of 0.47, a current ratio of 0.65 and a debt-to-equity ratio of 80.49. The company’s 50 day moving average price is GBX 6,380.64. The stock has a market cap of $46.73 billion and a P/E ratio of 21.62. Reckitt Benckiser Group has a twelve month low of GBX 5,559 ($72.64) and a twelve month high of GBX 7,174 ($93.74).

In other Reckitt Benckiser Group news, insider Adrian Nevil Hennah sold 13,701 shares of the company’s stock in a transaction dated Friday, May 10th. The shares were sold at an average price of GBX 6,143 ($80.27), for a total transaction of £841,652.43 ($1,099,767.97). Also, insider Andrew R. J. Bonfield bought 146 shares of the stock in a transaction on Tuesday, May 21st. The shares were bought at an average price of GBX 6,290 ($82.19) per share, for a total transaction of £9,183.40 ($11,999.74).

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Article: Short Selling Stocks and Day Traders

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with's FREE daily email newsletter.